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Preterm birth (PTB) is a leading cause of neonatal death worldwide 1 . Intrauterine and systemic infection and inflammation cause 30-40% of spontaneous preterm labor (PTL) 2 , which precedes PTB. Although antibody production is a major immune defense mechanism against infection, and B cell dysfunction has been implicated in pregnancy complications associated with PTL 3, 4 , the functions of B cells in pregnancy are not well known [5] [6] [7] [8] . We found that choriodecidua of women undergoing spontaneous PTL harbored functionally altered B cell populations. B cell-deficient mice were markedly more susceptible than wild-type (WT) mice to PTL after inflammation, but B cells conferred interleukin (IL)-10-independent protection against PTL. B cell deficiency in mice resulted in a lower uterine level of active progesterone-induced blocking factor 1 (PIBF1), and therapeutic administration of PIBF1 mitigated PTL and uterine inflammation in B cell-deficient mice. B cells are a significant producer of PIBF1 in human choriodecidua and mouse uterus in late gestation. PIBF1 expression by B cells is induced by the mucosal alarmin . Human PTL was associated with diminished expression of the a-chain of IL-33 receptor on choriodecidual B cells and a lower level of active PIBF1 in late gestation choriodecidua. These results define a vital regulatory cascade involving IL-33, decidual B cells and PIBF1 in safeguarding term pregnancy and suggest new therapeutic approaches based on IL-33 and PIBF1 to prevent human PTL.
PTB, defined as birth before 37 weeks of gestation in humans, affects 5-18% pregnancies worldwide and has remained an intractable cause of neonatal mortality and long-term morbidity 1 . Spontaneous PTL is an immediate predecessor to PTB in most cases 1 . Intrauterine and systemic infection and inflammation are recognized pathophysiologic mechanisms that account for 30-40% of this adverse clinical condition 2 . The host immune processes in infection-or inflammationdriven PTL and PTB remain unknown. Although antibody production by B cells is an important immune defense mechanism against mucosal and systemic infection, the function of B cells in pregnancy is poorly understood. B cells have long been considered to be rare or absent from the decidua [5] [6] [7] [8] . Maternal B cells undergo substantial modifications during pregnancy [10] [11] [12] [13] , presumably to assist the acceptance of a semi-allogeneic fetus, and B cell dysfunction has been implicated in pregnancy complications associated with PTL 3, 4 . We hypothesized that B cells have a crucial role in regulating pregnancy, and sought to better define the host protective immune pathways against PTL.
By analyzing specimens of women with spontaneous term labor (TL) or PTL (Supplementary Table 1) , we found that B cells were present in human choriodecidual stroma (Supplementary Fig. 1 ) and constituted approximately 1% and 2.5% of CD45 + cells in TL and PTL cases, respectively ( Fig. 1a-c) . Choriodecidual B cells exhibited a distinct phenotype from that of peripheral blood B cells, with higher expression of the activated, memory B cell-or plasma cell (PC)-associated molecules CD11c, CD27, CD38, CD70, CD80, CD86, CD95, CD138 and B cell maturation antigen (BCMA), lower expression of CD23 and C-C chemokine receptor 7 (CCR7), and a higher proportion of CD20 lo , CD22 lo , IgM lo and IgD lo cells ( Fig. 1d and Supplementary Fig. 2a,b) , a profile that is suggestive of higher activation, class switching, memory and plasmacytoid differentiation, and is consistent with tissue residency. Choriodecidual B cells also expressed CCR6 and the integrins α 4 and β 7 , but not CCR9, and only a little CCR10 (Supplementary Fig. 2b ), which promote lymphocyte homing to intestine and skin-associated Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor mucosal tissues, respectively [14] [15] [16] , indicating that B cell migration to choriodecidua involves nonoverlapping homing receptors from migration to other mucosal sites. Compared with TL choriodecidua, PTL choriodecidua harbored more B cells (Fig. 1a-c) and CD20 + CD70 − CD43 + CD27 + cells (Fig. 1e-g ), a population that has been postulated to be B-1 cells, which can spontaneously secrete autoreactive/polyreactive IgM 17 and has been implicated in other adverse pregnancy outcomes 3 , and more CD24 − CD38 hi PCs (Fig. 1h-j) . The expression of several direct or indirect B cell-stimulating molecules, including B cell-activating factor of the tumor necrosis factor family (BAFF), a proliferation-inducing ligand (APRIL) and thymic stromal lymphopoietin (TSLP) 18, 19 , was higher in choriodecidual epithelial and/or stromal cells of PTL subjects than TL subjects ( Supplementary Fig. 3a,b) , which might underlie the expansion and higher activation of B cells in PTL choriodecidua. Collectively, human PTL choriodecidua harbored B cells with altered functions that were characterized by aberrant expansion, and higher activation and antibody production as compared with TL choriodecidua.
B cells produce IL-10 to suppress systemic and local inflammation 20, 21 , and IL-10 is crucial for protection against inflammationinduced PTL in mice 22, 23 . IL-10 expression was lower in choriodecidual B cells in PTL subjects than in TL subjects (Fig. 1k,l) , although the total numbers of IL-10 + B cells were similar in TL and PTL choriodeciduas (Fig. 1m) . To determine whether B cells protect against PTL triggered by inflammation, we compared the susceptibility of WT C57BL/6 mice and B cell-deficient µMT mice to PTL induced by administration of lipopolysaccharides (LPS) on gestational day (gd) 16.5, a commonly used mouse model for human PTL triggered by systemic inflammation 2 . Although WT mice were relatively resistant to PTL and had a modest level of neonatal/fetal mortality after LPS administration, µMT mice experienced markedly higher rates of PTL and neonatal/fetal mortality (Fig. 2a,b ), which were accompanied by higher induction of uterine proinflammatory mediators ( Fig. 2c and Supplementary Fig. 4a ) and higher neutrophil infiltration into the uterus (Fig. 2d and Supplementary Fig. 4b,c) . Neutrophils in the uterus of µMT mice exhibited heightened activation, including higher expression of CD11b, CD18, intercellular adhesion molecule-1 (ICAM-1), major histocompatibility complex class II (MHC-II) and inducible nitric oxide synthase (iNOS), and lower expression of CD62L ( Fig. 2e and Supplementary Fig. 4d ). The proportions of uterine CD11b + Ly-6C + inflammatory monocytes were similar in WT and µMT mice (Supplementary Fig. 4e,f) , and induction of Ccl2 was comparable in WT and µMT uteri (Supplementary Fig. 4g ). Thus, B cells protect against PTL induced by inflammation in the third trimester in mice.
To determine whether B cells confer protection against PTL by producing IL-10, we administered LPS on gd 16.5 to µMT mice that received either syngeneic WT or syngeneic Il10 −/− B cells. Adoptive transfer of either WT or Il10 −/− B cells restored the resistance of µMT mice to PTL (Fig. 2f) , attenuated neonatal/fetal mortality (Fig. 2g) and suppressed uterine induction of pro-inflammatory mediators (Fig. 2h) and neutrophil infiltration (Fig. 2i) . Consistent with IL-10-independent protection, the uterus of µMT mice showed higher Il10 induction after LPS administration (Supplementary Fig. 5a ). The induction of transforming growth factor-β (TGF-β) 24, 25 and IL- 35 (refs. 26,27) , which contains Epstein-Barr-virus-induced gene 3 (EBI3) as a subunit 28 , was similar in WT and µMT mice ( Supplementary  Fig. 5b ). µMT mice that received WT or Il10 −/− B cells also showed a similar induction of uterine Ebi3 after LPS administration as compared to µMT mice that did not receive B cells (Supplementary Fig. 5c ).
Collectively, these data argue against a substantial role of IL-10, TGF-β or IL-35 in B cell-mediated protection against PTL.
Given that progesterone is important to the maintenance of term pregnancy 29 , we asked whether B cells are effectors in progesteronemediated immune regulation in late pregnancy. The progesteroneinducible molecule PIBF1 carries out many effector functions of progesterone in pregnancy 30 , and a lower serum concentration of PIBF1 in late pregnancy is associated with an increased risk of human PTL 31 . Full-length 90-kDa PIBF1 is a nucleus-or centrosome-associated protein 32 , whereas several alternatively spliced shorter isoforms, including the 35-, 48-, 57-and 67-kDa isoforms, can be secreted by certain tumor cells and by immune cells and trophoblasts during pregnancy, and are biologically active [32] [33] [34] . As compared with WT mice, µMT mice showed much lower active PIBF1 expression in late gestation uterus (Fig. 3a) and defective induction of uterine Pibf1 transcript after LPS administration (Fig. 3b) . However, WT and µMT mice had similar serum progesterone concentrations after LPS administration (Fig. 3c) . Transfer of WT or Il10 −/− B cells to µMT mice resulted in higher uterine active PIBF1 expression after LPS administration (Fig. 3d,e) . These results suggest that B cells are an important source of active PIBF1 in mouse uterus in late pregnancy. Flow cytometry and immunofluorescence further revealed that mouse uterine B cells expressed PIBF1 during mid-and late gestation (Fig. 3f) , and human choriodecidual B cells also expressed PIBF1 during late gestation (Fig. 3g,h and Supplementary Fig. 6a ). PIBF1 in choriodecidual B cells was both concentrated perinuclearly and distributed in the cytoplasm ( Fig. 3i and Supplementary Fig. 6b) , consistent with the localization of centrosome-associated and secretory PIBF1, respectively 33 . Of note, B cells were the cell population with the highest PIBF1 expression in mouse uterus ( Supplementary Fig. 7a−d ) and human choriodecidua ( Supplementary Fig. 8a−d) . Furthermore, human peripheral blood CD19 + B cells contained more full-length and active PIBF1 protein than other peripheral blood mononuclear cells (PBMCs), and PBMCs depleted of B cells were almost devoid of full-length and active PIBF1 (Supplementary Fig. 8e ). Thus, B cells are an important source of active PIBF1 in human choriodecidua and mouse uterus during late pregnancy.
To test whether B cell-mediated protection against PTL involves PIBF1 and whether therapeutic delivery of PIBF1 can promote resistance to PTL, we administered either phosphate-buffered saline (PBS) or recombinant human full-length PIBF1 (fPIBF1) to µMT mice before LPS challenge. As compared to PBS administration, fPIBF1 administration significantly lowered the rates of LPSinduced preterm delivery and neonatal/fetal mortality (Fig. 3j,k) , suppressed uterine induction of proinflammatory mediators ( Fig. 3l and Supplementary Fig. 9a ) and inhibited neutrophil infiltration into the uterus (Fig. 3m,n) . Uterine neutrophils exhibited lower activation in fPIBF1-treated versus PBS-treated mice after LPS challenge, with lower expression of CD11b, CD18, iNOS, ICAM-1 and MHC-II, and higher expression of CD62L ( Fig. 3o and Supplementary  Fig. 9b ). Administration of a recombinant C-terminal fragment of PIBF1 (cPIBF1) (Supplementary Fig. 10a ) neither mitigated PTL or neonatal/fetal death ( Supplementary Fig. 10b ,c) nor suppressed uterine neutrophil infiltration or activation triggered by LPS ( Supplementary Fig. 10d,e) . Thus, supplementation of PIBF1 promotes resistance to LPS-induced PTL in µMT mice, and the protective activity of PIBF1 resides in its N terminus.
We further sought to understand the regulation of PIBF1 expression by B cells and tested a panel of cytokines known to modulate B cell function. We performed quantitative real-time PCR andwestern blot analyses and found that IL-33 promoted PIBF1 expression by human peripheral blood B cells, similar to progesterone 35 ( Fig. 4a,b) . By contrast, interferon-γ (IFN-γ), IL-17A, IL-10 and TGF-β had no effect, and tumor necrosis factor (TNF) had a suppressive effect (Supplementary Fig. 11a and IL-33, only IL-33 induced PIBF1 expression by human B cells (Supplementary Fig. 11a ). Indeed, human peripheral blood or choriodecidual B cells did not express the receptors for IL-25 or TSLP (Supplementary Fig. 11b) Choriodecidua T e r m P r e t e r m B cell migration to choriodecidua in pregnancy may be mediated by signals involving α 4 and β 7 integrins. In response to choriodecidual IL-33, an alarmin that is released following uterine stress, inflammation and infection, choriodecidual B cells produce PIBF1 to suppress premature parturition, likely via the inhibition of the production of labor-inducing factors, natural killer (NK) cell activity, neutrophil infiltration and activation, and the production of proinflammatory mediators 30 . Thus, IL-33, choriodecidual B cells and PIBF1 constitute a protective axis to promote term pregnancy by counteracting uterine stress, inflammation and infection. In PTL, choriodecidual B cells undergo aberrant expansion, increased activation and differentiation into plasma cells or B-1 cells, and secrete antibodies that can trigger labor-inducing inflammatory cascades, such as complement and neutrophil activation. Furthermore, the protective axis involving IL-33, choriodecidual B cells and PIBF1 is defective in PTL, likely as a result of the aberrant downregulation of ST2L on choriodecidual B cells. *P < 0.05, **P < 0.01, ***P < 0.001, by two-tailed t test (a,j) or two-tailed Mann-Whitney U test (f,g).
gestation (Fig. 4c,d and Supplementary Fig. 12a-d) . Consistently, mouse uterine PIBF1 level did not decrease during progesterone withdrawal in late pregnancy (Supplementary Fig. 13a,b) . Thus, PIBF1 expression in mouse late gestation was maintained largely by IL-33 rather than progesterone. IL-33 is a mucosal alarmin that signals tissue damage following stress or infection 9 , and that can induce immune cells with regulatory functions to maintain tissue homeostasis [36] [37] [38] [39] [40] . Given that uterine stress and infection are causally linked to human PTL 2 , we asked whether human PTL encompasses defects in this protective pathway involving IL-33, decidual B cells and PIBF1. Although human peripheral blood and choriodecidual B cells constitutively expressed the β-chain of IL-33 receptor (IL-33R), interleukin-1 receptor accessory protein (IL1RAcP; Supplementary Fig. 14a−c) , the expression of the IL-33R α-chain, interleukin-1 receptor-like 1 (ST2L), was significantly lower on choriodecidual B cells in PTL subjects than in TL subjects (Fig. 4e-i) . PIBF1 expression in choriodecidua and choriodecidual B cells of subjects with PTL was concomitantly diminished (Fig. 4h-j) . The lower expression of PIBF1 or ST2L on choriodecidual B cells was unlikely to be a result of a lower choriodecidual progesterone level, because TL and PTL choriodecidual tissues contained similar levels of progesterone at delivery (Supplementary Fig. 15a) . Consistently, progesterone treatment did not lead to higher ST2L expression on cultured human B cells (Supplementary Fig. 15b) . Thus, human PTL is associated with defects in IL-33 responsiveness of and PIBF1 production by choriodecidual B cells independently of progesterone.
Taken together, our findings reveal an axis of B cell-mediated immune regulation that involves IL-33-dependent expression of PIBF1 and uncover a long-neglected, but vital, role of B cells in safeguarding term pregnancy that is defective in PTL (Fig. 4k) . Of note, although PIBF1 is recognized as a progesterone-induced molecule, our findings indicate that B cell-derived PIBF1 goes beyond being a progesterone effector molecule and has an important role in promoting tissue homeostasis in response to tissue stress independently of progesterone. The identification of this B cell-mediated protective pathway suggests new therapeutic strategies involving IL-33 and PIBF1 for the prevention and treatment of human PTL.
MeTHods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. Subjects with a current diagnosis of pre-eclampsia, a prior history or current diagnosis of diabetes, chronic hypertension, asthma, thyroid disease, pyelonephritis, active chlamydia, gonorrhea or syphilis infections, active HPV or HSV lesions, HIV infection and/or recreational drug use were excluded.
Human blood and tissue samples. Placentas and the attached chorioamniotic membranes were obtained after delivery. In each case, several random strips of the chorioamniotic membranes located at different regions of the choriodecidua were embedded in rolls in optimal cutting temperature (OCT) compound (Sakura Finetek 4583), frozen in liquid nitrogen and stored at −80 °C for immunofluorescence analysis. Choriodecidual tissues were scraped from the chorionic membranes that had blood clots removed, and digested with 0.2% (w/v) Clostridium histolyticum collagenase V (Sigma-Aldrich C9263) in RPMI-1640 with 10% FBS (Thermo Fisher Scientific 26140-079) at 37 °C with gentle agitation for 45 min. Cells released from the tissues were cleaned by being passed through a 100-µm cell strainer and centrifuged on a Ficoll gradient. Peripheral blood leukocytes of anonymous healthy donors after leukophoresis were obtained from the Southeast Michigan branch of American Red Cross with a protocol approved by the Institutional Review Board of Wayne State University and the DMC. Peripheral blood mononuclear cells (PBMCs) were isolated using Histopaque-1077 (Sigma-Aldrich 10771) following the manufacturer's instructions. Red blood cells were lysed using an ammoniumchloride-potassium lysing buffer (Thermo Fisher Scientific A1049201). IgD + B cells were purified from PBMCs by magnetic-activated cell sorting with a biotinylated goat F(ab′) 2 anti-human IgD antibody and anti-biotin magnetic microbeads (Miltenyi Biotec), as previously reported 41 . The purity of the IgD + B cells ranged from 92-99% as determined by flow cytometry with CD19 staining. CD19 + B cells were similarly separated from PBMCs using a biotinylated mouse anti-human CD19 (clone HIB19) antibody, with purity ranging from 93-97% as determined by flow cytometry using a different clone (SJ25C1) of CD19 antibody.
Mice. C57BL/6 mice (Jackson stock number 000664), Balb/c mice (Jackson stock number 000651), µMT (B6.129S2-Ighm tm1Cgn , Jackson stock number 002288) and Il10 −/− (B6.129P2-Il10 tm1Cgn , Jackson stock number 002251) mice in C57BL/6 background were purchased from the Jackson Laboratory. Il33 −/− lacZ reporter mice in the C57BL/6 background were generated by the mouse core of the NIH/NIAID Mucosal Immunology Studies Team at Washington University School of Medicine. All mice were maintained in the same specificpathogen-free facility of the Division of Laboratory Animal Resources of Wayne State University. All protocols were approved by Wayne State University Institutional Animal Care and Use Committee.
Mouse models of preterm labor. 6-10-week-old virgin female C57BL/6 (WT) or µMT mice were mated with male Balb/c mice. Female mice were examined daily in the early morning for the presence of a vaginal plug, which denoted gd 0.5. In the late morning of gd 16.5, pregnant female mice were intraperitoneally administered with 200 µl of sterile PBS or 200 µl of sterile PBS containing 0.5, 2.5, 5, 10 or 20 µg LPS from Salmonella enterica serotype typhimurium (SigmaAldrich L6143). The various doses of LPS were assigned to the mice randomly. In some experiments, splenic B cells of 5-8-week-old virgin female WT or Il10 −/− mice were purified using a mouse resting B cell negative isolation kit (Miltenyi Biotec 130-090-862) to 94-99% purity as determined by CD19 staining. 10 7 purified B cells were adoptively transferred in 200 µl sterile PBS into pregnant female µMT mice on gd 14.5 before LPS administration on gd 16.5. In some other experiments, 200 µl sterile PBS or 200 µl sterile PBS containing 1 µg recombinant full-length PIBF1 (fPIBF1) (aa 1-755, with an N-terminal glutathione-S-transferase (GST) tag, Abnova H00010464-P01) or 300 ng of a recombinant C-terminal fragment of PIBF1 (cPIBF1) (aa 660-755, with an N-terminal glutathione-S-transferase (GST) tag, Abnova H00010464-Q01) was intravenously administered to pregnant female µMT mice on gd 16.5 3 h before intraperitoneal LPS administration. 24 h after LPS administration, female mice were examined for delivery and death of delivered pups if delivery occurred. They were then killed for the examination of neonatal/fetal mortality, which was calculated as the total number of dead delivered pups and dead fetuses divided by the total number of implantation sites. Uteri were collected, briefly washed in PBS and processed for RNA and protein extraction or flow cytometry. The people performing the analysis were not blinded to the genotype or treatment of the mice.
Cell culture. Human PMBCs, IgD + B cells, CD19 + B cells or PBMCs depleted of CD19 + B cells were cultured in RPMI-1640 medium (Sigma-Aldrich R8578) supplemented with 2 mM l-glutamine, 2 mg/ml NaHCO 3 , 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B and 10% FBS. Cells were stimulated with 1 µM progesterone (Sigma-Aldrich P0130), or 100 ng/ml IL- RNA extraction and quantitative real-time polymerase chain reaction. RNA was extracted from cells or tissues using TRIzol (Thermo Fisher Scientific 15596026). cDNA synthesis was performed using the Superscript III firststrand synthesis system (Thermo Fisher Scientific 188080051) in a thermocycler (Bio-Rad T100). Quantitative real-time PCR was performed with Power SYBR Green PCR Master Mix (Thermo Fisher Scientific 4367660) in a StepOnePlus instrument (Applied Biosystems) using pairs of sense and antisense primers targeted at the genes of interest (Supplementary Table 2 ).
Flow cytometry and cell sorting. Cells were incubated with an Fc blocking reagent and stained at 4 °C with antibodies to various cell surface antigens (Supplementary Table 3 ). For staining of intracellular molecules, cells were subsequently fixed and permeabilized using a CytoFix/CytoPerm kit (BD 554722). Isotype-matched control antibodies were used to define the baseline staining for the molecules of interest. Cells or beads stained with each fluorochrome were used to establish fluorescent compensation. 7-aminoactinomycin D (7-AAD, Tonbo Biosciences 13-6993-T500 or BD Biosciences 559925) or Ghost Dye Violet 510 (Tonbo Biosciences 13-0870-T500) was used to identify dead cells in order to exclude them from the analysis. Events were acquired on an LSR II, LSRFortessa or FACSCanto II cytometer (BD Biosciences) and analyzed by FlowJo (Tree Star). In some experiments, stained cells were sorted using a SONY SH800 or SY3200 cell sorter (SONY Biotechnology).
Imaging flow cytometry. Choriodecidual cell suspensions were incubated with an Fc blocking reagent and stained at 4 °C with antibodies to various surface antigens, fixed and permeabilized, and stained for PIBF1 or with an isotype control antibody, followed by a fluorochrome-conjugated secondary antibody (Supplementary Table 3 ). Nuclei were counter stained with Hoechst 33342 (Thermo Fisher Scientific 62249). Cells or beads stained with each fluorochrome were used to establish fluorescent compensation. Cells were imaged on an ImageStream X Mark II imaging flow cytometer (Amnis) and data were analyzed using IDEAS 6.1 (Amnis).
Immunohistochemistry. Frozen human tissues were stored at −80 °C shortly before sectioning. 6-7-µm tissue sections were made using a cryostat (Leica CM1950). Sections were fixed with 4% paraformaldehyde, permeabilized in PBS containing 0.2% Triton X-100, blocked with PBS containing 10 mg/ml bovine serum albumin (BSA) and 100 µg/ml human IgG. Endogenous biotin was subsequently blocked with an Avidin/Biotin blocking kit (Thermo Fisher Scientific 004303). The tissues were stained with primary antibodies against target antigens isotype control antibodies from the same company with the same conjugation, if the primary antibody is conjugated followed by alkaline-phosphatase-or horseradish-peroxidase-conjugated secondary antibodies
